Table 1 Baseline characteristics in study groups

From: Distinct spatiotemporal patterns of white matter hyperintensity progression

 

Stroke patient (main data)

Low-risk control (control data)

High-risk control (control data)

n

9179

13,811

22,399

Age, year (SD)

67.3 (13.0)L,H

61.6 (7.3)S,H

64.8 (7.4)S,L

Sex, male % (n)

58.8 (5395)L,H

38.5 (5326)S,H

51.4 (11504)S,L

HTN, % (n)

64.8 (5948)C

30.6 (11074)S

DM, % (n)

30.3 (2780)C

5.8 (2099)S

HL, % (n)

27.5 (2523)C

17.6 (6384)S

Smoking, % (n)

40.6 (3726)C

36.9 (13346)S

AF, % (n)

20.2 (1850)C

3.8 (1368)S

CAD, % (n)

9.9 (909)C

6.9 (2486)S

Stroke subtypes, % (n)

LAA

37.8 (3468)

  

SVS

16.6 (1524)

  

CE

21.5 (1975)

  

Others

24.1 (2212)

  

Acute infarct volume (IQR), ml

2.46 (0.64‒13.77)

  

Admission NIHSS score (IQR)

4 (2‒9)

  
  1. SD standard deviation, HTN hypertension, DM diabetes mellitus, HL hyperlipidemia, AF atrial fibrillation, CAD coronary artery disease, LAA large artery atherosclerosis, SVS small vessel stroke, CE cardioembolism, IQR interquartile range, NIHSS National Institute of Health Stroke Scale.
  2. S,L,H,CTwo-sided P < 0.05 for group difference (vs. stroke patient, vs. low-risk control, vs. high-risk control, and vs. entire control group, respectively) from multivariate analysis of variance.
Back to article page